共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R026072-10mg | 10mg | 5~7个工作日 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
|
|
罗恩 | R026072-50mg | 50mg | 5~7个工作日 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
|
|
罗恩 | R026072-5mg | 5mg | 5~7个工作日 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
|
|
阿拉丁 | T126012-5mg | 5mg | 现货 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
|
|
阿拉丁 | T126012-25mg | 25mg | 现货 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
|
|
阿拉丁 | T126012-100mg | 100mg | 现货 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
|
|
阿拉丁 | T409225-1ml | 1ml | 现货 |
Tivozanib (AV-951) Tivozanib (AV-951) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ0071FM-5mg | 5mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... Tivozani |
98+% |
|
|
凯为 | JZ0071FM-50mg | 50mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... Tivozani |
98+% |
|
|
凯为 | JZ0071FM-100mg | 100mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... Tivozani |
98+% |
|
|
凯为 | JZ0071FM-250mg | 250mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... Tivozani |
98+% |
|
|
凯为 | JZ0071FM-1g | 1g | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... Tivozani |
98+% |
|
|
毕得 | BD208778-50mg | 50mg | 现货 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
|
|
毕得 | BD208778-100mg | 100mg | 现货 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
|
|
毕得 | BD208778-5mg | 5mg | 现货 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
|
|
毕得 | BD208778-250mg | 250mg | 现货 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
|
|
毕得 | BD208778-1g | 1g | 现货 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
|
|
百灵威 | JK1232599-5MG | 5MG | 1天 |
替沃扎尼 Tivozanib, 99% |
99% |
|
|
百灵威 | JK1232599-100MG | 100MG | 1天 |
替沃扎尼 Tivozanib, 99% |
99% |
|
|
百灵威 | JK1232599-25MG | 25MG | 1天 |
替沃扎尼 Tivozanib, 99% |
99% |
|
|
TRC | T447205-10mg | 10mg | 期货,请咨询 |
替沃扎尼 Tivozani |
>95% |
|
|
TRC | T447205-50mg | 50mg | 期货,请咨询 |
替沃扎尼 Tivozani |
>95% |
|
|
Matrix | MA125526-500mg | 500mg | 3-4周 |
1-(2-Chloro-4-((6,7-dimethox... 1-(2-Chloro-4-((6,7-dimethox... |
98% | 咨询 | 请联系客服购买! |
Matrix | MA125526-1g | 1g | 3-4周 |
1-(2-Chloro-4-((6,7-dimethox... 1-(2-Chloro-4-((6,7-dimethox... |
98% | 咨询 | 请联系客服购买! |
Apollo | BIFK0002-5mg | 5mg | 3-4周 |
Tivozanib Tivozani |
|
|
|
Apollo | BIFK0002-10mg | 10mg | 3-4周 |
Tivozanib Tivozani |
|
|
|
Apollo | BIFK0002-25mg | 25mg | 3-4周 |
Tivozanib Tivozani |
|
|
|
安耐吉 | E022998-100mg | 100mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-chloro-4-((6,7-dimethox... |
97% |
|
|
安耐吉 | E022998-1g | 1g | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-chloro-4-((6,7-dimethox... |
97% |
|
|
安耐吉 | E022998-250mg | 250mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-chloro-4-((6,7-dimethox... |
97% |
|
|
安耐吉 | E022998-50mg | 50mg | 期货,请咨询 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-chloro-4-((6,7-dimethox... |
97% |
|
|
源叶 | S27192-5mg | 5mg | 期货,请咨询 |
Tivozanib (AV-951) Tivozanib (AV-951) |
>96%,VEGFR抑制剂 |
|
|
源叶 | S27192-10mg | 10mg | 现货 |
Tivozanib (AV-951) Tivozanib (AV-951) |
>96%,VEGFR抑制剂 |
|
|
源叶 | S27192-100mg | 100mg | 期货,请咨询 |
Tivozanib (AV-951) Tivozanib (AV-951) |
>96%,VEGFR抑制剂 |
|
|
源叶 | T93992-1ml | 1ml | 期货,请咨询 |
Tivozanib (AV-951) Tivozanib (AV-951) |
10mM in DMSO |
|
|
Target Mol | T2456-1mg | 1mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-2mg | 2mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-5mg | 5mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-10mg | 10mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-50mg | 50mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-100mg | 100mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-200mg | 200mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-1mL | 1mL | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Target Mol | T2456-25mg | 25mg | 现货 |
替沃扎尼 Tivozani |
98.23% |
|
|
Am | A770204-100mg | 100mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
Am | A770204-5mg | 5mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
Am | A770204-10mg | 10mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
Am | A770204-1mg | 1mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
Am | A770204-50mg | 50mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
Am | A770204-250mg | 250mg | 现货 |
Tivozanib Tivozani |
98+% |
|
|
MCE | HY-10977-200mg | 200mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-100mg | 100mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-50mg | 50mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-10mg | 10mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-10mM*1mL | 10mM*1mL | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-5mg | 5mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|
MCE | HY-10977-1mg | 1mg | 现货 |
Tivozanib Tivozani |
99.37% |
|
|